e-therapeutics reported results for the full year to Jan 31st 2018; business updates reflect good progress on the main research programs. Cash balance of £9.6mn was slightly higher than we expected, thanks to careful cost management.  

e-Therapeutics plc

e-Therapeutics plc

We are an Oxford-based company with a unique and powerful computer-based drug discovery platform and a specialised approach to network biology. 

Our novel methodology and our Discovery Engine allow us to discover new and better drugs in a more efficient and effective way.

Market: AIM
52-week High/Low:
Sector: Pharma & Biotech
Market Cap: 7.52M

Popular Content

Tag Content

e-Therapeutics plc Timeline